Prevention of infection and bleeding in leukemic patients receiving intensive remission maintenance therapy
β Scribed by Preisler, H. D. ;Early, A. ;Hryniuk, W.
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- English
- Weight
- 466 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0098-1532
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Leukemic patients were treated with intensive chemotherapy to reduce the number of leukemic cells remaining after complete remission was induced. This therapy resulted in periods of severe granulocytopenia and thrombocytopenia. Considering 13 patients who did not receive antibacterial prophylaxis, documented infection was quite common including four episodes of bacteremia and three urinary tract infections. By contrast, patients who received coβtrimoxazole as antibacterial prophylaxis experienced one half as many febrile episodes and no serious infections. Prophylactic coβtrimoxazole is beneficial for patients with marrow remission in this study. Similar benefit in patients with leukemic marrows remains to be established. All patients received prophylactic platelet transfusions three times a week when their platelet counts were < 20,000/ΞΌl. There were no episodes of bleeding other than petechiae.
π SIMILAR VOLUMES
The biologic impact and clinical toxicity of Corynebacterium parvum administered at a dose of 5 mg/M2 by intravenous or subcutaneous routes were evaluated in 18 children receiving combination chemotherapy for maintenance of acute lymphoblastic leukemia (ALL) in remission. Several nonspecific immunol
Background: Concentrations of proinflammatory cytokines are increased in the intestinal mucosa of patients with active Crohn's disease (CD). In a prospective study we investigated whether cytokines can predict long-term remission (ΟΎ6 months) in patients with steroid-refractory CD receiving treatment